These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28488219)

  • 1. Inhibition of Gelatinases (MMP-2 and MMP-9) by Withania somnifera Phytochemicals Confers Neuroprotection in Stroke: An In Silico Analysis.
    Kumar G; Patnaik R
    Interdiscip Sci; 2018 Dec; 10(4):722-733. PubMed ID: 28488219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring neuroprotective potential of Withania somnifera phytochemicals by inhibition of GluN2B-containing NMDA receptors: An in silico study.
    Kumar G; Patnaik R
    Med Hypotheses; 2016 Jul; 92():35-43. PubMed ID: 27241252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis,
    Gaurav I; Singh T; Thakur A; Kumar G; Rathee P; Kumari P; Sweta K
    Curr Pharm Biotechnol; 2020; 21(15):1674-1687. PubMed ID: 32614743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An integrated computational and experimental approach to gaining selectivity for MMP-2 within the gelatinase subfamily.
    Fabre B; Filipiak K; Díaz N; Zapico JM; Suárez D; Ramos A; de Pascual-Teresa B
    Chembiochem; 2014 Feb; 15(3):399-412. PubMed ID: 24449516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of matrix metalloproteinase (MMP)-2 and MMP-9 in the ischemic stroke.
    Kurzepa J; Kurzepa J; Golab P; Czerska S; Bielewicz J
    Int J Neurosci; 2014 Oct; 124(10):707-16. PubMed ID: 24304146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional mimetic peptide discovery isolated by phage display interacts selectively to fibronectin domain and inhibits gelatinase.
    Shoari A; Rasaee MJ; Kanavi MR; Daraei B
    J Cell Biochem; 2019 Dec; 120(12):19699-19711. PubMed ID: 31270859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for the selective inhibitors of MMP-9 from natural products based on pharmacophore modeling and molecular docking in combination with bioassay experiment, hybrid QM/MM calculation, and MD simulation.
    Hou J; Zou Q; Wang Y; Gao Q; Yao W; Yao Q; Zhang J
    J Biomol Struct Dyn; 2019 Aug; 37(12):3135-3149. PubMed ID: 30079817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New in Vivo Compatible Matrix Metalloproteinase (MMP)-2 and MMP-9 Inhibitors.
    Beutel B; Song J; Konken CP; Korpos E; Schinor B; Gerwien H; Vidyadharan R; Burmeister M; Li L; Haufe G; Sorokin L
    Bioconjug Chem; 2018 Nov; 29(11):3715-3725. PubMed ID: 30277751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anacardic acid inhibits the catalytic activity of matrix metalloproteinase-2 and matrix metalloproteinase-9.
    Omanakuttan A; Nambiar J; Harris RM; Bose C; Pandurangan N; Varghese RK; Kumar GB; Tainer JA; Banerji A; Perry JJ; Nair BG
    Mol Pharmacol; 2012 Oct; 82(4):614-22. PubMed ID: 22745359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and discovery of (I-3,II-3)-biacacetin as a novel non-zinc binding inhibitor of MMP-2 and MMP-9.
    Nanjan P; Nambiar J; Nair BG; Banerji A
    Bioorg Med Chem; 2015 Jul; 23(13):3781-7. PubMed ID: 25907368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular docking studies of a group of hydroxamate inhibitors with gelatinase-A by molecular dynamics.
    Hou T; Zhang W; Xu X
    J Comput Aided Mol Des; 2002 Jan; 16(1):27-41. PubMed ID: 12197664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural insights into the binding mode of flavonols with the active site of matrix metalloproteinase-9 through molecular docking and molecular dynamic simulations studies.
    Pradiba D; Aarthy M; Shunmugapriya V; Singh SK; Vasanthi M
    J Biomol Struct Dyn; 2018 Nov; 36(14):3718-3739. PubMed ID: 29068268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of matrix metalloproteinase-2 and 9 by Piroxicam confer neuroprotection in cerebral ischemia: an in silico evaluation of the hypothesis.
    Mazumder MK; Bhattacharya P; Borah A
    Med Hypotheses; 2014 Dec; 83(6):697-701. PubMed ID: 25459137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Withania somnifera root extract inhibits MGO-induced skin fibroblast cells dysfunction via ECM-integrin interaction.
    Liu X; Chen C; Lin Y; Liu Y; Cai S; Li D; Li L; Xiao P; Yi F
    J Ethnopharmacol; 2024 Apr; 323():117699. PubMed ID: 38185262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple receptor-ligand based pharmacophore modeling and molecular docking to screen the selective inhibitors of matrix metalloproteinase-9 from natural products.
    Gao Q; Wang Y; Hou J; Yao Q; Zhang J
    J Comput Aided Mol Des; 2017 Jul; 31(7):625-641. PubMed ID: 28623487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational investigation of phytochemicals from
    Ahmad I; Kumar D; Patel H
    J Biomol Struct Dyn; 2022 Oct; 40(17):7991-8003. PubMed ID: 33970806
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibitors of gelatinases (MMP-2 and MMP-9) for the management of hematological malignancies.
    Das S; Amin SA; Jha T
    Eur J Med Chem; 2021 Nov; 223():113623. PubMed ID: 34157437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insight into the structural requirement of aryl sulphonamide based gelatinases (MMP-2 and MMP-9) inhibitors - Part I: 2D-QSAR, 3D-QSAR topomer CoMFA and Naïve Bayes studies - First report of 3D-QSAR Topomer CoMFA analysis for MMP-9 inhibitors and jointly inhibitors of gelatinases together.
    Das S; Amin SA; Jha T
    SAR QSAR Environ Res; 2021 Aug; 32(8):655-687. PubMed ID: 34355614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carborane-Containing Matrix Metalloprotease (MMP) Ligands as Candidates for Boron Neutron-Capture Therapy (BNCT).
    Lutz MR; Flieger S; Colorina A; Wozny J; Hosmane NS; Becker DP
    ChemMedChem; 2020 Oct; 15(20):1897-1908. PubMed ID: 32720425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding ligands driven mechanism of wild and mutant aryl hydrocarbon receptor in presence of phytochemicals combating Parkinson's disease: an
    Rath SN; Jena L; Patri M
    J Biomol Struct Dyn; 2020 Feb; 38(3):807-826. PubMed ID: 30836878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.